MedTrace Logo

Chronic Kidney Disease, Hyperkalemia and Echocardiographic Changes

NCT06635590 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-10-10

No results posted yet for this study

Summary

Patients with CKD ( eGFR \< \<60 mL/min/1,73 m2) presenting to emergency department with isolated hyperkalemia will be study population. Pre and post treatment ECG and echocardiographic findings will be recorded. Investigator will not intervene with the treatment decision of responsible physician and will not delay any intervetion or treatment for the sake of study.

Data will be compared in terms of ECHO and ECG findings depending on hyperkalemia level and response to treatment.

Conditions

  • Chronic Kidney Disease (CKD)
  • Hyperkalemia
  • Hemodialysis

Sponsors & Collaborators

  • Saglik Bilimleri Universitesi

    lead OTHER

Principal Investigators

  • gulsen akcay, ass. prof. · ass. prof. of organization

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2025-02-01
Completion
2025-02-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06635590 on ClinicalTrials.gov